Evidence map›Paper›PMID 14999294›Full record

ArticleLeukemia2004

Deletion of 7p or monosomy 7 in pediatric acute lymphoblastic leukemia is an adverse prognostic factor: a report from the Children's Cancer Group.

N A Heerema, J B Nachman, H N Sather, M K La, R Hutchinson, B J Lange, B Bostrom, P G Steinherz, P S Gaynon, F M Uckun and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Leukemia, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Early T-cell precursor acute lymphoblastic leukemia withProceedings (Baylor University. Medical Center) · 2018
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. T-cell Acute Lymphoblastic Leukemia with del (7) (q11.2q22) and Aberrant Expression of Myeloid Markers.International journal of hematology-oncology and stem cell research · 2013
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 9 institutions in 1 country.

N A HeeremaThe Ohio State University, Columbus, OH, USA. heerema-1@medctr.osu.edu
J B Nachman
H N Sather
M K La
R Hutchinson
B J Lange
B Bostrom
P G Steinherz
P S Gaynon
F M Uckun
Children's Cancer Group
Children's Oncology Group · USChildren's Hospital of Philadelphia · USChildren’s Minnesota - St. Paul Hospital · USKettering University · USParker Hughes Cancer Center · USThe Ohio State University · USUniversity of California, Los Angeles · USUniversity of Chicago · USUniversity of Michigan–Ann Arbor · US

Funding

CHILDRENS CANCER STUDY GROUP CHAIRMAN'S GRANTU10CA013539 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI REAMAN, GREGORY H · 1985 to 2002
$43.1M
PROGNOSIS OF NEWLY DIAGNOSED AND RELAPSED ALLU01CA060437 · NCI · NATIONAL CHILDHOOD CANCER FOUNDATION · PI UCKUN, FATIH M · 1993 to 1996
–
NCI NIH HHS CA-13539NCI NIH HHS CA-60437
6 · The paper itself

Abstract

Monosomy 7 or deletions of 7q are associated with many myeloid disorders; however, the significance of such abnormalities in childhood acute lymphoblastic leukemia (ALL) is unknown. Among 1880 children with ALL, 75 (4%) had losses involving chromosome 7, 16 (21%) with monosomy 7, 41 (55%) with losses of 7p (del(7p)), 16 (21%) with losses of 7q (del(7q)), and two (3%) with losses involving both arms. Patients with losses involving chromosome 7 were more likely to be > or =10 years old, National Cancer Institute (NCI) poor risk, and hypodiploid than patients lacking this abnormality. Patients with or without these abnormalities had similar early response to induction therapy. Event-free survival (EFS) and survival for patients with monosomy 7 (P<0.0001 and P=0.0007, respectively) or del(7p) (P<0.0001 and P=0.0001, respectively), but not of patients with del(7q), were significantly worse than those of patients lacking these abnormalities. The poorer EFS was maintained after adjustment for a Philadelphia (Ph) chromosome, NCI risk status, ploidy, or an abnormal 9p. However, the impact on survival was not maintained for monosomy 7 after adjustment for a Ph. These results indicate that the critical region of loss of chromosome 7 in pediatric ALL may be on the p-arm.

Indexed as

Chromosome DeletionChromosomes, Human, Pair 7MonosomyChildChild, PreschoolHumansPrecursor Cell Lymphoblastic Leukemia-LymphomaPrognosis

Identifiers

PMID14999294
OpenAlexW2013900672

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.